MDC 21 : Injuries, poisonings and toxic effects of drugs


12,608 Diagnosis Codes are assigned to this MDC

T45.624A Poisoning by hemostatic drug, undetermined, initial encounter
T45.624S Poisoning by hemostatic drug, undetermined, sequela
T45.625A Adverse effect of hemostatic drug, initial encounter
T45.625S Adverse effect of hemostatic drug, sequela
T45.691A Poisoning by other fibrinolysis-affecting drugs, accidental (unintentional), initial encounter
T45.691S Poisoning by other fibrinolysis-affecting drugs, accidental (unintentional), sequela
T45.692A Poisoning by other fibrinolysis-affecting drugs, intentional self-harm, initial encounter
T45.692S Poisoning by other fibrinolysis-affecting drugs, intentional self-harm, sequela
T45.693A Poisoning by other fibrinolysis-affecting drugs, assault, initial encounter
T45.693S Poisoning by other fibrinolysis-affecting drugs, assault, sequela
T45.694A Poisoning by other fibrinolysis-affecting drugs, undetermined, initial encounter
T45.694S Poisoning by other fibrinolysis-affecting drugs, undetermined, sequela
T45.695A Adverse effect of other fibrinolysis-affecting drugs, initial encounter
T45.695S Adverse effect of other fibrinolysis-affecting drugs, sequela
T45.7X1A Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), initial encounter
T45.7X1S Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), sequela
T45.7X2A Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, initial encounter
T45.7X2S Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, sequela
T45.7X3A Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, initial encounter
T45.7X3S Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, sequela
T45.7X4A Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, initial encounter
T45.7X4S Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, sequela
T45.7X5A Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter
T45.7X5S Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, sequela
T45.8X1A Poisoning by other primarily systemic and hematological agents, accidental (unintentional), initial encounter
T45.8X1S Poisoning by other primarily systemic and hematological agents, accidental (unintentional), sequela
T45.8X2A Poisoning by other primarily systemic and hematological agents, intentional self-harm, initial encounter
T45.8X2S Poisoning by other primarily systemic and hematological agents, intentional self-harm, sequela
T45.8X3A Poisoning by other primarily systemic and hematological agents, assault, initial encounter
T45.8X3S Poisoning by other primarily systemic and hematological agents, assault, sequela
T45.8X4A Poisoning by other primarily systemic and hematological agents, undetermined, initial encounter
T45.8X4S Poisoning by other primarily systemic and hematological agents, undetermined, sequela
T45.8X5A Adverse effect of other primarily systemic and hematological agents, initial encounter
T45.8X5S Adverse effect of other primarily systemic and hematological agents, sequela
T45.91XA Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), initial encounter
T45.91XS Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), sequela
T45.92XA Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, initial encounter
T45.92XS Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, sequela
T45.93XA Poisoning by unspecified primarily systemic and hematological agent, assault, initial encounter
T45.93XS Poisoning by unspecified primarily systemic and hematological agent, assault, sequela
T45.94XA Poisoning by unspecified primarily systemic and hematological agent, undetermined, initial encounter
T45.94XS Poisoning by unspecified primarily systemic and hematological agent, undetermined, sequela
T45.95XA Adverse effect of unspecified primarily systemic and hematological agent, initial encounter
T45.95XS Adverse effect of unspecified primarily systemic and hematological agent, sequela
T46.0X1A Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), initial encounter
T46.0X1S Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), sequela
T46.0X2A Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, initial encounter
T46.0X2S Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, sequela
T46.0X3A Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, initial encounter
T46.0X3S Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, sequela
T46.0X4A Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, initial encounter
T46.0X4S Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, sequela
T46.0X5A Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter
T46.0X5S Adverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela
T46.1X1A Poisoning by calcium-channel blockers, accidental (unintentional), initial encounter
T46.1X1S Poisoning by calcium-channel blockers, accidental (unintentional), sequela
T46.1X2A Poisoning by calcium-channel blockers, intentional self-harm, initial encounter
T46.1X2S Poisoning by calcium-channel blockers, intentional self-harm, sequela
T46.1X3A Poisoning by calcium-channel blockers, assault, initial encounter
T46.1X3S Poisoning by calcium-channel blockers, assault, sequela
T46.1X4A Poisoning by calcium-channel blockers, undetermined, initial encounter
T46.1X4S Poisoning by calcium-channel blockers, undetermined, sequela
T46.1X5A Adverse effect of calcium-channel blockers, initial encounter
T46.1X5S Adverse effect of calcium-channel blockers, sequela
T46.2X1A Poisoning by other antidysrhythmic drugs, accidental (unintentional), initial encounter
T46.2X1S Poisoning by other antidysrhythmic drugs, accidental (unintentional), sequela
T46.2X2A Poisoning by other antidysrhythmic drugs, intentional self-harm, initial encounter
T46.2X2S Poisoning by other antidysrhythmic drugs, intentional self-harm, sequela
T46.2X3A Poisoning by other antidysrhythmic drugs, assault, initial encounter
T46.2X3S Poisoning by other antidysrhythmic drugs, assault, sequela
T46.2X4A Poisoning by other antidysrhythmic drugs, undetermined, initial encounter
T46.2X4S Poisoning by other antidysrhythmic drugs, undetermined, sequela
T46.2X5A Adverse effect of other antidysrhythmic drugs, initial encounter
T46.2X5S Adverse effect of other antidysrhythmic drugs, sequela
T46.3X1A Poisoning by coronary vasodilators, accidental (unintentional), initial encounter
T46.3X1S Poisoning by coronary vasodilators, accidental (unintentional), sequela
T46.3X2A Poisoning by coronary vasodilators, intentional self-harm, initial encounter
T46.3X2S Poisoning by coronary vasodilators, intentional self-harm, sequela
T46.3X3A Poisoning by coronary vasodilators, assault, initial encounter
T46.3X3S Poisoning by coronary vasodilators, assault, sequela
T46.3X4A Poisoning by coronary vasodilators, undetermined, initial encounter
T46.3X4S Poisoning by coronary vasodilators, undetermined, sequela
T46.3X5A Adverse effect of coronary vasodilators, initial encounter
T46.3X5S Adverse effect of coronary vasodilators, sequela
T46.4X1A Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), initial encounter
T46.4X1S Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), sequela
T46.4X2A Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, initial encounter
T46.4X2S Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, sequela
T46.4X3A Poisoning by angiotensin-converting-enzyme inhibitors, assault, initial encounter
T46.4X3S Poisoning by angiotensin-converting-enzyme inhibitors, assault, sequela
T46.4X4A Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, initial encounter
T46.4X4S Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, sequela
T46.4X5A Adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter
T46.4X5S Adverse effect of angiotensin-converting-enzyme inhibitors, sequela
T46.5X1A Poisoning by other antihypertensive drugs, accidental (unintentional), initial encounter
T46.5X1S Poisoning by other antihypertensive drugs, accidental (unintentional), sequela
T46.5X2A Poisoning by other antihypertensive drugs, intentional self-harm, initial encounter
T46.5X2S Poisoning by other antihypertensive drugs, intentional self-harm, sequela
T46.5X3A Poisoning by other antihypertensive drugs, assault, initial encounter
T46.5X3S Poisoning by other antihypertensive drugs, assault, sequela